Natalie Galanina, MD

Researcher Spotlight: Natalie Galanina, MD The University of Chicago Though ibrutinib (Imbruvica) has helped a large number of lymphoma patients, many patients treated with ibrutinib eventually develop a resistance to the therapy and relapse. Dr. Galanina’s Lymphoma Clinical Research Mentoring…







